English NHS Failing To Meet Targets For Availability Of NICE-Approved Cancer Drugs

Pink Sheet analysis shows that availability targets for cancer drugs approved under the UK’s Early Access to Medicines Scheme are routinely missed. (Shutterstock)

More from Europe

More from Market Access